24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
75% |
|
PEPTIDOMIMETIC CD40L BINDING |
25% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
EBOLA |
78.57% |
|
CANCER |
14.29% |
|
PEPTIDOMIMETIC CD40L BINDING |
7.14% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
EBOLA |
78.57% |
|
CANCER |
14.29% |
|
PEPTIDOMIMETIC CD40L BINDING |
7.14% |